GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
종목 코드 WGSWW
회사 이름GeneDx Holdings Corp
상장일Sep 04, 2020
CEOMs. Katherine A. Stueland
직원 수- -
유형Company Warrant
회계 연도 종료- -
주소333 Ludlow Street
도시STAMFORD
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호06902
전화18887291206
웹사이트https://sema4.com/
종목 코드 WGSWW
상장일Sep 04, 2020
CEOMs. Katherine A. Stueland
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음